Home
/
Development course

2022.4

(Summary description)On April 12, 2022, the company submitted the registration application of "Nifedipine controlled release tablets" to the National Drug Evaluation Center.

2022.4

(Summary description)On April 12, 2022, the company submitted the registration application of "Nifedipine controlled release tablets" to the National Drug Evaluation Center.

Information

On April 12, 2022, the company submitted the registration application of "Nifedipine controlled release tablets" to the National Drug Evaluation Center.

Scan the QR code to read on your phone

Previous: 2022.5
Next: 2021.7
Previous: 2022.5
Next: 2021.7
Previous : 2022.5
Next : 2021.7
Previous : 2022.5
Next : 2021.7

Recommended news

"Venlafaxine hydrochloride sustained release tablets" by Hefei City the first three new product certification

2023-03-29

Hefei Huafang Medicine won the Anhui Provincial Patent Excellence Award

2020-10-22

Hefei Huafang Pharmaceutical's independent research and development project "Key Technology Breakthrough and Industrial Application of Oral Solid Preparations" won the first prize of Anhui Science and Technology Progress Award

2021-04-13

Hefei Huafang Medicine organized special training lectures on "Civil Code"

2020-10-19

The total investment is 30.88 billion yuan! Signing text of the first batch of projects in the high-tech block of Hefei area of ​​Anhui Pilot Free Trade Zone: [Large] [Middle]

2020-10-19

Huafang Pharmceutical Sciences

Hotline：0551-65551391

Fax：0551-65336396

Add： Building D-5, Technology Industrial Park, 168 Xiangzhang Avenue, National High-tech Zone, Hefei City

Huafang

Wechat

Huafang

Mobile

Copyright © Huafang Pharmceutical

Verification 皖ICP备10206584号-1
Sitemap
Market
Job
Team spirit
Honor
Public welfare
Company News
Copyright